Revvity (RVTY) Other Accumulated Expenses (2014 - 2016)

Revvity (RVTY) posted Other Accumulated Expenses of $126.1 million for Q1 2016, up 2.59% quarter-over-quarter from $123.0 million in Q4 2014, and up 2.59% year-on-year from $123.0 million in Q1 2015.

Revvity (RVTY) Other Accumulated Expenses (2014 - 2016) Analysis & Trends

Revvity (RVTY) has reported Other Accumulated Expenses for 2 consecutive years, with $126.1 million the latest figure, recorded in Q1 2016.

  • Other Accumulated Expenses for Q1 2016 came in at $126.1 million, up 2.59% year-over-year; the trailing twelve-month figure through Jan 2016 was $126.1 million (up 2.59% YoY), and the FY2016 annual result was $126.1 million, up 2.59% from the prior year.
  • Other Accumulated Expenses was $126.1 million for Q1 2016 at Revvity, up from $123.0 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $126.1 million in Q1 2016 and troughed at $123.0 million in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Revvity 12.62 Bn 11.76 Bn 387.66 Mn

Historic Data

Download Data
DateValue
Jan 3, 2016 126.14 Mn
Dec 28, 2014 122.96 Mn